Tempus AI vs Xylem, Inc. — how do they compare? Tempus AI trades at $49.1 (market cap $8.69B), while Xylem, Inc. trades at $117.66 (market cap $28.67B). The key difference: Xylem, Inc. is far larger — about 3.3× Tempus AI's market cap, and Xylem, Inc. pays a 1.43% dividend while Tempus AI pays none. Which is the better fit depends on your goals.
| TEM | XYL | |
|---|---|---|
Market Cap | $8.69B | $28.67B |
Sector | Broad Market / Factor | Industrials |
52-Week High | $103.25 | $152.95 |
52-Week Low | $42.37 | $106.34 |
Enterprise Value | $9.37B | $29.92B |
Dividend Yield | — | 1.43% |
Trailing returns across standard periods
Latest headlines on both assets
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →Xylem is a global leader in water technology and offers a wide range of solutions, including the transport, treatment, testing, and efficient use of water for customers in the utility, industrial, commercial, and residential sectors. Xylem was spun off from ITT in 2011. Based in Rye Brook, New York, Xylem has a presence in over 150 countries and employs 16,200. The company generated $6.2 billion in revenue and $611 million in adjusted operating income in 2021.
Read more on XYL →